A Phase 2 Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer (CANOPY)

Status: Open to Accrual

Learn more: 

• clinicaltrials.gov: #NCT05502315

Study Contact: studies@hoosiercancer.org; (317) 921-2050.